Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 October 2018 | Story UFS | Photo Varsity Sports
First ever netball final in Bloemfontein
The Kovsies will be aiming to lift the Varsity Netball trophy in front of their home supporters on Monday when they face Tuks in the final in the Callie Human Centre.

The netball team of the University of the Free State, once again after five years, earned themselves the right to stage a final in the Varsity Netball competition. The two-time champion, the Dream Team, qualified for the final after topping the log and then wiping the floor with the Maties on Monday (1 October 2018) in the semi-final. The score was 56-45. 

They will come up against Tuks in the Callie Human Centre on the UFS Bloemfontein Campus for the final tonight. The match will get underway at 18:45.

The team won the very first two years of the competition in 2013 and 2014. On both occasions, they had to play away from home – in 2013 against the Pukke in Potchefstroom and in 2014 against Tuks in Pretoria. 

It will be the fourth meeting between the Kovsies and Tuks within three months. The Free State students won the group fixture in August by 68-43, but Tuks had to do without a number of their star players. At the University Sport South Africa tournament in Bloemfontein during July, Tuks triumphed twice, winning the final by 48-30.

Apart from the winners’ medals, an award will be handed to the tournament’s top player. Centre Khanyisa Chawane is one of three finalists. The winner gets chosen through public votes.

Dream Team players have won the prize four of the five times. Ané Botha was crowned in 2013, Karla Pretorius in 2014 and 2015, and last year it was the turn of current Kovsie player, Khomotso Mamburu.

To vote for Chawane, click here hover your mouse over the like button and choose the heart emoticon. Voting is closing on 5 October and the winner will be announced after the final.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept